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012.04.0Abstract We have been evaluating different therapeutic modalities using acute MPI, & we aimed
at the use of acute MPI as a predictor of patients in need for urgent revascularization.
Methods: A total of 85 patients with ACS were included in our study, 57 males, mean age
52.9 ± 10.6 years, 35% were diabetics, 50% hypertensive, 54% smokers, 30% dyslipidemic &
33% had +ve family history of CAD. Acute MPI was done by SPECT technique using triple head
Gamma Camera. Every patient had two sets of images, ﬁrst set done on admission by injecting
25 mCi Tc99m SestaMIBI intravenously before initiating therapeutic intervention and acquired
within 6 h of injection. Second set of images was acquired 2 days later. Myocardium at risk
(MAR) was calculated using 20 segment scoring system from the 1st set of images (scale 0–4/seg-
ment). Residual ischemia (RI) was calculated from the second set of images. Salvage index
(SI =MAR  RI/MAR · 100) was taken as an end point for successful reperfusion (SI > 30%).0 Elmekias Street, Manial,
om (A. Abdelbary).
tian Society of Cardiology.
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166 A. Abdelbary et al.All risk factors and MPI parameters were analyzed as independent predictors for the need for
urgent revascularization vs. conservative strategy.
Results: Patients were subdivided according to therapeutic modalities used into three groups,
group I: (50 pts) received unfractionated heparin, group II: (20 pts) received low molecular weight
heparin & group III: (15 pts) received GPIIb/IIIa. There was no statistical difference as regards risk
factors, age, sex, & MAR. Salvage index was highest in group II & lowest in group I (39 ± 21% vs.
64 ± 33.6% vs. 58 ± 25%) P= 0.07. Successful reperfusion was achieved in 67.3% in group I &
90% of group II, 86.7% in group III (P= 0.06). Out of 85 pts, 31 patients (group A) were in need
for inhospital target vessel revascularization & 54 patients (group B) showed a good response on
medical treatment (conservative strategy). Compared to group B, group A had higher values of
RI (11 ± 7 vs. 5 ± 4%, P< 0.0001) & lower SI (15 ± 6 vs. 67 ± 24%, P< 0.0001) despite similar
MAR (14 ± 7 vs. 15 ± 8) P> 0.05. High SI > 60%, and absence of diabetes (DM) were good pre-
dictors for conservative management strategy (speciﬁcity 96%); however, SI < 30% as well as pres-
ence of DM may recognize patients in need for urgent revascularization (sensitivity 50%) with
overall predictive accuracy of 78.8%.
Conclusion: AcuteMPI is a useful tool for evaluating therapeutic interventions. SI > 60% as well as
absence of DM could recognize the subset of patients who can be managed conservatively whereas
SI < 30% as well as presence of DM may recognize patients in need for urgent revascularization.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction & aim of work
Acute myocardial perfusion imaging (MPI) has been recom-
mended to conﬁrm the diagnosis of non-ST elevation acute
coronary syndromes (NSTEACS) in patients with chest pain
and inconclusive electrocardiogram.1,2 However, risk stratiﬁ-
cation of acute coronary syndromes (ACS) patients usually re-
quires stress MPI prior to discharge. Patients who are admitted
on clinical background and negative biomarkers need stress
evaluation and or other imaging modalities.1,3,4
Over the past decade many therapies had emerged for the
treatment of NSTEACS starting with unfractionated heparin
(UFH), low molecular weight heparin (LMWH), and glyco-
protein IIb/IIIa (GPIIb/IIIa) inhibitors.3,4 Acute MPI may
be used in patients with ACS not only for diagnostic purposes
but to evaluate the extent of the myocardium at risk and to
determine the effects of therapeutic interventions.5–7,1 Strong
correlation has been noted between infarct related artery pa-
tency and decrease in perfusion defect size.5–7
1.1. Aim
Over the last 12 years we have been using acute technetium
Hexa – methoxy isobutyryl isonitrile (Tc99m SestaMIBI) MPI
to compare different emerging therapies of ACS.8–13 In this
study we aimed at searching the value of a second rest image
after medical treatment to evaluate three main treatment
modalities, and if rest–rest MPI can be used to select patients
in need for urgent invasive vs. elective invasive strategies.
2. Patients & methods
 A retrospective study involving 85 NSTEACS patients
admitted to the Critical Care Center, Cairo University,
and subjected to two sets of rest MPI which aimed at eval-
uating certain therapeutic interventions. We reviewed
patient records for:
– Detailed history & physical examination.– Twelve lead electrocardiograms (ECGs) on admission &
follow-up.
– Biomarkers including cardiac enzymes creatinine kinase
(CK), creatinine kinase myocardial band (CK-MB), la-
ctate dehydrogenase (LDH) & or troponin T during the
admission period.
 Acute MPI was acquired as follows: every patient had two
sets of images.5,6
2.1. First set
The patient was injected on admission by 10–12 mCi of Tc99m
SestaMIBI, images were acquired after initial stabilization &
within 6 h by single photon emission computed tomography
(SPECT) technique, using triple head Siemens gamma camera
20 images were acquired, 20 s each, over 120 arc starting at
45 to obtain the classic short axis, vertical long axis & hori-
zontal long axis slices.
The defect size was quantiﬁed using the 20 segment scoring
system (six segments in apical, mid ventricular & basal short
axis slices & two segments in apical vertical long axis slices).14,15
Each segment received a score of 0–4 according to its
involvement where:
0 = normal uptake,
1 = mild defect,
2 = moderate defect,
3 = severe defect and
4 = no photon activity.
The defect size was estimated as a percent of the myocar-
dium and calculated as follows: sum of scores in the 20 seg-
ments/80 · 100 to get the myocardium at risk (MAR).
2.2. Second set of images
Obtained 48–72 h after starting therapy using the same tech-
nique at rest. The scoring system was applied and calculated
in the same way to obtain the residual ischemia (RI).
Figure 1 Scintigraphic success.
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SI ¼MARRI=MAR 100
The physicians & patients were blinded to the results of acute
MPI.
All data were analyzed & processed using the Emory tool
box version 5.1:
2.3. Therapy
All patients received:
 Intravenous infusion of nitroglycerin.
 Aspirin 300 mg orally on admission then 150 mg once daily.
 Beta blockers starting with propranolol 10 mg orally every
8 h & dose titrated as needed unless contraindicated.
 Fifty patients studied received unfractionated heparin.
 Initial bolus dose of 80 IU/kg followed by heparin intrave-
nous infusion of 18 IU/kg/h.
 Twenty patients included received lowmolecular weight hep-
arin (enoxaparine 1 mg/kg/12 h) & 15 included patients
received combined half dose unfractionated heparin & tiroﬁ-
ban (0.4 ug/kg over 30 min followed by 0.1 ug/kg/h for 48 h).
2.4. Need for revascularization
Patients were subjected to urgent revascularization in cases
of2,3,15:
 Refractory angina.
 Development of myocardial infarction as evidenced by
ECG & or elevated cardiac enzymes.
 Newly developed left ventricular dysfunction.
2.5. End points
 If salvage index was >30% therapy was considered
successful.17
 Need for revascularization.
3. Results
Eighty-ﬁve unstable angina patients were included in the study
including 57 males & 28 females (mean age 52.9 ± 10.6 years,
range 39–80 years) (Table 1).
3.1. Acute MPI parameters
Mean MAR was 15 ± 7.6%, mean RI was 7.36 ± 6.5% &
mean SI was 48.5 ± 52%.Table 1 Risk factors for coronary artery disease in studied
patients.
Risk factor %
DM 35
HTN 50
Smoking 54
Dyslipidemia 30
+ve FH 33Therapy was considered scintigraphically successful
(SI > 30%) in 65 pts (Fig. 1).
3.2. Clinical parameters
According to clinical criteria 31 patients were subjected to ur-
gent revascularization procedure due to:
 Refractory angina in 25 pts.
 Progression to MI in six patients.
Accordingly patients were subdivided into two groups.
Group A (31 patients): who needed urgent revascularization.
Group B (54 patients): who were stable on medical treatment &
scheduled for elective angiography after discharge.
Group B showed signiﬁcantly higher salvage index & signif-
icantly lower residual ischemia with similar myocardium at
risk (Table 2).
Scintigraphic success rate after initial medical treatment
alone was signiﬁcantly higher in group B when compared to
group A.
When analyzed acute MPI parameters as predictor for ur-
gent need of revascularization. Patients with salvage index
>60% can be managed conservatively while patients with
SI < 30% may need urgent revascularization.
However in patients with SI between 31% & 59% MPI had
no predictive value (speciﬁcity 96%, sensitivity 50%) & overall
predictive accuracy of 78.8% (Fig. 2, Table 3).
3.3. Acute MPI for evaluating different therapies
According to initial therapy used patients were classiﬁed into
three groups:
Group I: (UFH group) 50 patients.
Group II: (LMWH group) 20 patients.
Group III: (GPIIb/IIIa inhibitors) 15 patients.
3.4. Risk factors in three groups
There was no signiﬁcant difference between three groups as re-
gards risk factors for coronary artery disease (CAD) (Table 4).Table 2 Acute imaging parameters in two groups myocar-
dium at risk (MAR), residual ischemia (RI) and salvage index
(SI).
Group A (%) Group B (%) P value
Myocardium at risk 14 ± 7 15 ± 8 0.7
Residual ischemia 11 ± 7 5 ± 4 0.0001
Salvage index 15 ± 6 67 ± 24 0.0001
Table 3 Patients distribution according to salvage index.
SI <30 >30–59 >60
No. of pts 20 23 42
Table 4 Risk factors in different groups according to therapy.
Risk factor G I (%) G II (%) G III (%) P value
DM 28 45 46.70 0.24
HTN 23 55 60 0.57
Dyslipidemia 24 30 53.30 0.09
Smoking 56 40 66.7 0.27
+ve FH 34 25 40 0.627
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Figure 2 The ROC curve showing the predictive value of rest
MPI NSTEACS.
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Need for urgent revascularization was similar in groups I & II
& lower in group III (Table 5).Table 5 Patients referred for urgent revascularization in different t
UFH
Refractory angina 16 (32%)
Progression to MI 4 (8%)
Need for revascularization 20 (40%)
Table 6 Acute scintigraphic parameters in different therapeutic gro
Scintigraphic parameter UFH LMW
MAR (%) 13.6 ± 8 13.2
RI (%) 8.15 ± 7.5 4.5
SI (%) 39 ± 21 643.5. Comparison between acute MPI parameters in three groups
Endpoint therapy was considered scintigraphically successful
(SI > 30%) in 67.3% of group I, 90% of group II & 86.7%
of group III, P= 0.07 (Table 6).
When compared to the unfractionated heparin group the
LMWH group showed insigniﬁcant difference in the MAR
(P= 0.8) with signiﬁcantly lower residual ischemia (0.008) &
higher salvage index (0.05).
4. Discussion
Our study demonstrated the possible value of acute myocardial
perfusion imaging using Tc99m SestaMIBI, in hospital plan-
ning of patients with unstable angina. At least patients who
had salvage index >60% after 24–48 h can be managed con-
servatively with medical treatment alone without subjecting
them to stress modalities.2
American Society of Nuclear Cardiology (ASNC) and
American Heart Association (AHA) guidelines recommended
acute MPI as a diagnostic tool in ACS patients with normal
or inconclusive ECG & biomarkers presenting to the emer-
gency department.2
However, these patients still need further re-assessment by
stress–rest MPI prior to discharge.2,3,16
We suggest that patients with SI > 60% in rest/rest images
may be deferred to future elective coronary angiography spe-
cially in busy cath. labs.
Our study has postulated that acute MPI parameters
namely salvage index >60% after 24–48 h of medical treat-
ment can effectively exclude those patients from need for ur-
gent revascularization without need for further stress–rest
testing and as adjunctive or even as a placement to clinical risk
stratiﬁcation or positive biomarkers. In addition acute MPI
can be used as a subjective evidence of improvement in myo-
cardial ischemic burden with its known superiority over
ECG & symptomatology.
Our study lacks the long term follow-up for those patients
managed conservatively so it is recommended to conduct a lar-
ger clinical trial with longer term follow-up to verify these
results.
Based on the current results we recommend a follow-up
clinical study for patients presenting to ER with chest painherapeutic groups.
LMWH GPIIb/IIIa inhibitors
7 (35%) 2 (13.3%)
2 (10%) –
9 (45%) 2 (13.3%)
ups.
H GPIIb/IIIa inhibitor P value
± 4.4 22.1 ± 5.8 0.001
± 3.5 8.5 ± 4.7 0.078
± 33.6 58 ± 25 0.07
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rest image after medical treatment alone for 24 h.
4.1. Different therapies
Despite inhomogeneity in the MAR between the three groups
tested which could be attributed to inhomogeneous sample
size, LMWH & GPIIb/IIIa inhibitors seem to be at least as
equal to or superior to UFH in management of ACS.
The accurate estimation of salvage index as actual measure-
ment of response at tissue level is a superior endpoint to clin-
ical & ECG improvement. MPI can be used safely & effectively
for monitoring the response to treatment after 24 h; however,
it lacks hour to hour monitoring where clinical & ECG are
superior.
Currently GPIIb/IIIa inhibitors are of limited use in the
management of NSTEACS and that they are stratiﬁed in class
III before subjecting patients to coronary angiography yet in
our study they showed superiority over other antithrombotics
used.
Despite higher MAR in the GPIIb/IIIa inhibitors group,
those patients showed better clinical & scintigraphic outcomes
when compared to those patients receiving UFH or LMWH
alone with a lower need for urgent in hospital revasculariza-
tion. This may point toward the additional value of GPIIb/IIIa
in the management of unstable angina (UA) patients apart
from their use as a preparatory step for urgent
revascularization.
5. Conclusion
 Acute MPI before & after initial medical treatment used for
stabilization of ACS patients can clearly identify those
patients who can be managed conservatively & may act as
additional information for those who are in need for urgent
target vessel revascularization (TVR).
 LMWH & GPIIb/IIIa inhibitors may be superior or at least
equal to unfractionated heparin in improving myocardial
perfusion.
6. Recommendations
 Use acute rest MPI & rest MPI after 24–48 h may be an
additional useful tool for risk stratifying patients with UA
and to guide in hospital management strategy.
 A longer term follow-up may show us more data about the
reliability of acute MPI as a prognostic modality.
 Larger trials are recommended to verify the predictive role
of acute MPI & to postulate the value of GPIIb/IIIa as an
initial treatment in UA patients.
 Glycoprotein IIb/IIIa inhibitors may have a role in initial
management of patients with unstable angina & may
decrease the need for urgent revascularization.
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